Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer
Purpose: The RadTox assay measures circulating cell-free DNA released in response to radiotherapy (RT)-induced tissue damage. The primary objectives for this clinical trial were to determine whether cell-free DNA numbers measured by the RadTox assay are (1) correlated with body integral dose, (2) lo...
Main Authors: | Natalie A. Lockney, MD, Randal Henderson, MD, Steven G. Swarts, PhD, Zhenhuan Zhang, MD, PhD, Bingrong Zhang, DVM, MD, Jennifer Li, BS, Robert A. Zlotecki, MD, PhD, Christopher G. Morris, MS, Katherine Casey-Sawicki, MA, Paul Okunieff, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Particle Therapy Co-operative Group
2020-09-01
|
Series: | International Journal of Particle Therapy |
Subjects: | |
Online Access: | https://theijpt.org/doi/pdf/10.14338/IJPT-20-00033.1 |
Similar Items
-
Measuring Radiation Toxicity Using Circulating Cell-Free DNA in Prostate Cancer Patients
by: Casey-Sawicki, K.A, et al.
Published: (2022) -
Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma
by: David H. Abramson, MD, et al.
Published: (2021-03-01) -
New device for sperm preparation involving migration-gravity sedimentation without centrifugation compared with density-gradient centrifugation for normozoospermic intrauterine insemination
by: Kenichi Tatsumi, M.D., Ph.D., et al.
Published: (2020-09-01) -
Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset
by: Kazuto Nishio, MD, PhD, et al.
Published: (2021-06-01) -
Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial
by: Takeo Odaka, MD, PhD, et al.
Published: (2017-01-01)